[Federal Register Volume 74, Number 196 (Tuesday, October 13, 2009)]
[Notices]
[Page 52492]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-24483]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Advisory Committee on Blood Safety and 
Availability

AGENCY: Department of Health and Human Services, Office of the 
Secretary.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S. 
Department of Health and Human Services is hereby giving notice that 
the Advisory Committee on Blood Safety and Availability (ACBSA) will 
hold a meeting. The meeting will be open to the public.

DATES: The meeting will take place Thursday, November 19 and Friday, 
November 20, 2009 from 8:30 a.m. to 5 p.m.

ADDRESSES: The Universities at Shady Grove, 9630 Gudelsky Drive, 
Rockville, MD 20850, Phone: 301-738-6000.

FOR FURTHER INFORMATION CONTACT: Jerry A. Holmberg, PhD, Executive 
Secretary, Advisory Committee on Blood Safety and Availability, Office 
of Public Health and Science, Department of Health and Human Services, 
1101 Wootton Parkway, Suite 250, Rockville, MD 20852, (240) 453-8803, 
FAX (240) 453-8456, e-mail <a href="/cdn-cgi/l/email-protection#18595b5a4b595870706b367f776e"><span class="__cf_email__" data-cfemail="460705041507062e2e3568212930">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: The Advisory Committee on Blood Safety and 
Availability provides advice to the Secretary and the Assistant 
Secretary for Health on a range of policy issues that impact (1) 
Definition of public health parameters around safety and availability 
of the blood supply and blood products, (2) broad public health, 
ethical and legal issues related to transfusion and transplantation 
safety, and (3) the implications for safety and the availability of 
various economic factors affecting product cost and supply.
    In keeping with its established mission, the ACBSA has been asked 
to review and comment on the current processes and parameters which 
should be used in the decision-making process for transplantation 
safety policy. At the November 19 and 20, 2009 meeting, the Committee 
will be asked to comment and make recommendations on current safety 
decision making processes within the Department of Health and Human 
Services while considering those same processes within the Private 
Sector.
    During the meeting, the ACBSA will be provided a briefing on 
Biovigilance (surveillance of blood, organs, and tissues safety). 
Specifically, the committee will be asked to comment on the white paper 
entitled, ``Biovigilance in the United States: Efforts to Bridge a 
Critical Gap in Patient Safety and Donor Health.''
    The public will have opportunity to present their views to the 
Committee on both meeting days. A public comment session has been 
scheduled for November 19 and 20, 2009. Comments will be limited to 
five minutes per speaker and must be pertinent to the discussion. Pre-
registration is required for participation in the public comment 
session. Any member of the public who would like to participate in this 
session is encouraged to contact the Executive Secretary at his/her 
earliest convenience. It is requested that those who wish to have 
printed material distributed to the Committee provide thirty (30) 
copies of the document to be distributed to the Executive Secretary, 
ACBSA, prior to close of business November 16, 2009. If it is not 
possible to provide 30 copies of the material to be distributed, then 
individuals are requested to provide at a minimum one (1) copy of the 
document(s) to be distributed prior to the close of business November 
16, 2009. It also is requested that any member of the public who wishes 
to provide comments to the Committee utilizing electronic data 
projection submit the necessary material to the Executive Secretary 
prior to close of business November 16, 2009.

    Dated: September 25, 2009.
Jerry A. Holmberg,
Executive Secretary, Advisory Committee on Blood Safety and 
Availability.
[FR Doc. E9-24483 Filed 10-9-09; 8:45 am]
BILLING CODE 4150-41-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>